Global Health Limited (BOM:543654)
India · Delayed Price · Currency is INR 1,327.80
-8.85 (-0.66%)
At close: Jul 13, 2026
Global Health Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Global Health stock has a consensus rating of "Strong Buy" and an average price target of ₹1,421. The average 1-year stock price forecast is 7.01% higher than the current stock price, while the lowest is ₹1,210 (-8.87%) and the highest is ₹1,570 (+18.24%).
Price Target: ₹1,421 (+7.01%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Global Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 8 | 11 | 11 |
| Buy | 4 | 5 | 5 | 4 | 4 | 4 |
| Hold | 5 | 4 | 4 | 4 | 2 | 2 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 15 | 16 | 17 | 17 |
Financial Forecast
Revenue This Year
51.69B
from 44.10B
Increased by 17.20%
Revenue Next Year
59.44B
from 51.69B
Increased by 14.99%
EPS This Year
25.83
from 20.69
Increased by 24.86%
EPS Next Year
32.25
from 25.83
Increased by 24.82%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 55.8B | ||
| Avg | 51.7B | ||
| Low | 49.1B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 26.6% | ||
| Avg | 17.2% | ||
| Low | 11.3% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 28.20 | ||
| Avg | 25.83 | ||
| Low | 22.90 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 36.3% | ||
| Avg | 24.9% | ||
| Low | 10.7% |